公司资料
Nuvation Bio 股价、新闻与催化剂
- 股票代码:
- NUVB
- 交易所:
- NYSE
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
6.93 USD (+1.46%)
收盘价
最后更新: 2026年8月21日
1.71B USD
市值
股价为何变动
As of Aug 21, 2026, NUVB closed up 1.46% at $6.93. No new same-company headline was identified in the current news window.
公司概览
业务概览
Nuvation Bio is an oncology company developing targeted cancer therapies and other precision-oncology assets. Its strategy is to build a focused cancer pipeline with broad therapeutic potential.
所在地与行业分类
Headquartered in the United States and listed on NYSE, Nuvation sits in specialty oncology biotechnology.
商业模式特征
The business depends on clinical data, pipeline selection, and the ability to translate oncology programs into value.
生物医药行业定位
Nuvation is a catalyst-sensitive oncology company whose valuation will depend on clinical and strategic progress.
未来催化剂
- Nuvation Bio’s catalysts are taletrectinib and any regulatory or data update in ROS1-positive lung cancer. The market will care about whether the asset can keep building a real oncology franchise.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。